A Luminescent Oxygen Channeling Immunoassay for the Determination of Insulin in Human Plasma

This publication has 20 references indexed in Scilit:

• Multiplexed Analysis of Biomarkers Related to Obesity and the Metabolic Syndrome in Human Plasma, Using the Luminex-100 System
  Clinical Chemistry, 2005
• Solid-Phase Immunoassays in Mechanism-Based Drug Discovery: Their Application in the Development of Inhibitors of the Molecular Chaperone Heat-Shock Protein 90
  ASSAY and Drug Development Technologies, 2005
• A Sensitive, Robust High-Throughput Electrochemiluminescence Assay for Rat Insulin
  SLAS Discovery, 2004
• A "Mix and Read" Assay for Insulin Using Fluorometric Microvolume Assay Technology
  ASSAY and Drug Development Technologies, 2003
• Technical note: time-resolved fluoro-immunometric assay for intact insulin in livestock species
  Journal of Animal Science, 2002
• Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast‐gradient liquid chromatography/tandem mass spectrometry
  Rapid Communications in Mass Spectrometry, 2001
• Pharmacokinetic screening for the selection of new drug discovery candidates is greatly enhanced through the use of liquid chromatography–atmospheric pressure ionization tandem mass spectrometry
  Journal of Chromatography A, 1997
• Lead development: Validation and application of high throughput screening for determination of pharmacokinetic parameters for enzyme inhibitors
  Bioorganic & Medicinal Chemistry, 1996
• Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.
  Proceedings of the National Academy of Sciences, 1994
• Biotinylation of human C3
  Molecular Immunology, 1982